539 related articles for article (PubMed ID: 7867144)
1. Interrupting the transmission of wild polioviruses with vaccines: immunological considerations.
Ghendon Y; Robertson SE
Bull World Health Organ; 1994; 72(6):973-83. PubMed ID: 7867144
[TBL] [Abstract][Full Text] [Related]
2. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
3. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Orenstein WA;
Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
[TBL] [Abstract][Full Text] [Related]
4. Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses.
Thompson KM; Kalkowska DA; Duintjer Tebbens RJ
Vaccine; 2015 Mar; 33(13):1568-77. PubMed ID: 25701673
[TBL] [Abstract][Full Text] [Related]
5. Eradication of poliomyelitis in the United States.
Nathanson N
Rev Infect Dis; 1982; 4(5):940-50. PubMed ID: 7146731
[TBL] [Abstract][Full Text] [Related]
6. Global eradication of poliomyelitis: reinvent the wheel or use existing options effectively?
Ogra PL
Public Health Rev; 1993-1994; 21(1-2):143-50. PubMed ID: 8041881
[TBL] [Abstract][Full Text] [Related]
7. [Risk of introduction and spread of polioviruses in closed-type child-care facilities].
Romanenkova NI; Bichurina MA; Rozaeva NP; Kanaeva OI
Zh Mikrobiol Epidemiol Immunobiol; 2014; (6):90-5. PubMed ID: 25816521
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
Moĭseieva HV; Zadorozhna VI
Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
[TBL] [Abstract][Full Text] [Related]
9. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.
Fine PE; Carneiro IA
Am J Epidemiol; 1999 Nov; 150(10):1001-21. PubMed ID: 10568615
[TBL] [Abstract][Full Text] [Related]
10. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
Friedrich F
Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
[TBL] [Abstract][Full Text] [Related]
11. Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.
Duintjer Tebbens RJ; Pallansch MA; Kalkowska DA; Wassilak SG; Cochi SL; Thompson KM
Risk Anal; 2013 Apr; 33(4):703-49. PubMed ID: 23521018
[TBL] [Abstract][Full Text] [Related]
12. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
[TBL] [Abstract][Full Text] [Related]
13. A developing country perspective on vaccine-associated paralytic poliomyelitis.
John TJ
Bull World Health Organ; 2004 Jan; 82(1):53-7; discussion 57-8. PubMed ID: 15106301
[TBL] [Abstract][Full Text] [Related]
14. Interrupting wild poliovirus transmission using oral poliovirus vaccine: environmental surveillance in high-risks area of India.
Chowdhary R; Dhole TN
J Med Virol; 2008 Aug; 80(8):1477-88. PubMed ID: 18551602
[TBL] [Abstract][Full Text] [Related]
15. Decision analysis in planning for a polio outbreak in the United States.
Jenkins PC; Modlin JF
Pediatrics; 2006 Aug; 118(2):611-8. PubMed ID: 16882814
[TBL] [Abstract][Full Text] [Related]
16. Update on vaccine-derived polioviruses--worldwide, July 2009-March 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(25):846-50. PubMed ID: 21716199
[TBL] [Abstract][Full Text] [Related]
17. Strengths and weaknesses of current polio vaccines--a view from industry.
André FE
Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
[TBL] [Abstract][Full Text] [Related]
18. Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria.
Kalkowska DA; Duintjer Tebbens RJ; Thompson KM
J Infect Dis; 2014 Nov; 210 Suppl 1():S412-23. PubMed ID: 25316863
[TBL] [Abstract][Full Text] [Related]
19. An Introduction to Poliovirus: Pathogenesis, Vaccination, and the Endgame for Global Eradication.
Minor PD
Methods Mol Biol; 2016; 1387():1-10. PubMed ID: 26983727
[TBL] [Abstract][Full Text] [Related]
20. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
Duintjer Tebbens RJ; Thompson KM
J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
